LINC02139: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC02139

NCBI ID: G400548

LINC02139

Other Name(s): long intergenic non-protein coding RNA 2139 | Long intergenic non-protein coding RNA 2139

LINC02139: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Introduction

LINC02139 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as a potential drug target or biomarker. It is located within the human chromosome 6 and has been shown to play a role in various biological processes, including cell growth, development, and disease. In this article, we will provide an overview of LINC02139, its potential drug target status, and its potential as a biomarker for various diseases.

Overview of LINC02139

LINC02139 is a transcribed RNA molecule that is located within the chromome 6 and has a length of approximately 220 nucleotides. It is characterized by its ability to interact with various protein-coding genes, which has led to its classification as a long non-coding RNA (lncRNA). LINC02139 is expressed in various tissues and cells of the human body and has been shown to play a role in various biological processes, including cell growth, development, and disease.

Potential Drug Target Status

LINC02139 has been shown to interact with various proteins, including the protein encoded by the gene PDGF-RF. PDGF-RF is a potent signaling molecule that plays a role in tissue repair and regeneration. LINC02139 has been shown to regulate the activity of PDGF- RF, which suggests that it may be a potential drug target.

In addition to its potential role as a drug target, LINC02139 has also been shown to be a potential biomarker for various diseases. For example, LINC02139 has been shown to be downregulated in various diseases, including cancer, and may be a potential biomarker for these diseases. Additionally, LINC02139 has been shown to be involved in various signaling pathways, including the cell-cycle pathway and the Wnt signaling pathway. These findings suggest that LINC02139 may be a potential biomarker for various diseases.

Potential Biomarker Status

LINC02139 has been shown to play a role in various biological processes and has been identified as a potential biomarker for various diseases. For example, LINC02139 has been shown to be involved in the development and progression of cancer, as well as the regulation of cell growth and differentiation. Additionally, LINC02139 has been shown to be involved in various signaling pathways, including the cell-cycle pathway and the Wnt signaling pathway. These findings suggest that LINC02139 may be a potential biomarker for various diseases.

Conclusion

In conclusion, LINC02139 is a long intergenic non-protein-coding RNA that has been shown to play a role in various biological processes and has potential as a drug target or biomarker for various diseases. Further research is needed to fully understand the role of LINC02139 in these processes and to determine its potential as a drug or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2139

The "LINC02139 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02139 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets